| Literature DB >> 30609666 |
Johnna A Birbeck1, Judy A Westrick2, Grace M O'Neill3, Brian Spies4, David C Szlag5.
Abstract
Fast and reliable workflows are needed to quantitate microcystins (MCs), a ubiquitous class of hepatotoxic cyanotoxins, so that the impact of human and environmental exposure is assessed quickly and minimized. Our goal was to develop a high-throughput online concentration liquid chromatography tandem mass spectrometry (LC/MS/MS) workflow to quantitate the 12 commercially available MCs and nodularin in surface and drinking waters. The method run time was 8.5 min with detection limits in the low ng/L range and minimum reporting levels between 5 and 10 ng/L. This workflow was benchmarked by determining the prevalence of MCs and comparing the Adda-ELISA quantitation to our new workflow from 122 samples representing 31 waterbodies throughout Michigan. The frequency of MC occurrence was MC-LA > LR > RR > D-Asp³-LR > YR > HilR > WR > D-Asp³-RR > HtyR > LY = LW = LF, while MC-RR had the highest concentrations. MCs were detected in 33 samples and 13 of these samples had more than 20% of their total MC concentration from MCs not present in US Environmental Protection Agency (US EPA) Method 544. Furthermore, seasonal deviations between the LC/MS/MS and Adda-ELISA data suggest Adda-ELISA cross-reacts with MC degradation products. This workflow provides less than 24-h turnaround for quantification and also identified key differences between LC/MS/MS and ELISA quantitation that should be investigated further.Entities:
Keywords: Adda-ELISA; LC/MS/MS; Michigan lakes; cyanotoxins; microcystin; online concentration
Mesh:
Substances:
Year: 2019 PMID: 30609666 PMCID: PMC6356304 DOI: 10.3390/toxins11010013
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Map of Michigan and sampling sites.
Figure 2Chromatogram of selected microcystins (MCs), nodularin, and surrogate standard (L). A: D-Asp3-MC-RR; B: MC-RR; C: Nodularin; D: MC-YR; E: MC-HtyR; F: MC-LR; G: D-Asp3-MC-LR; H: MC-HilR; I: MC-WR; J: MC-LY; K: MC-LA; L: C2D5-MC-LR; M: MC-LW; and N: MC-LF.
Equations used for method validation.
| Validation Procedure | Equation |
|---|---|
| Initial demonstration of precision: |
|
| Initial demonstration of accuracy: |
|
| MRL confirmation using the Half Rang for the prediction interval of results (HRPIR) | HRPIR = 3.963 |
| Upper PIR limit | |
|
| |
| Lower PIR limit | |
|
| |
| Detection Limit (DL) determination |
|
σ = standard deviation; = mean; n = number of replicates; t( = Student’s t value for the 99% confidence level with n − 1 degrees of freedom.
Comparison of online concentration liquid chromatography tandem mass spectrometry (LC/MS/MS) method and US EPA Method 544 validation.
| Compound | DL (ng/L) | EPA 544 DL (ng/L) [ | MRL (ng/L) | Upper PIR | Lower PIR |
| %RSD | %Rec |
|---|---|---|---|---|---|---|---|---|
| D-Asp3-MC-RR | 0.6 | 5 | 122.46 | 98.32 | 0.9994 | 2.76 | 110 | |
| MC-RR | 0.6 | 1.2 | 5 | 118.66 | 93.98 | 0.9998 | 2.93 | 106 |
| Nodularin | 0.9 | 1.8 | 10 | 104.89 | 85.45 | 0.9999 | 2.58 | 95 |
| MC-YR | 3.6 | 4.6 | 10 | 147.37 | 70.86 | 0.9980 | 8.85 | 109 |
| MC-HtyR | 2.6 | 10 | 117.91 | 62.17 | 0.9996 | 7.81 | 90 | |
| MC-LR | 3.8 | 4.3 | 10 | 131.90 | 50.57 | 0.9988 | 11.25 | 91 |
| D-Asp3-MC-LR | 1.7 | 5 | 141.78 | 70.82 | 0.9996 | 8.42 | 106 | |
| MC-HilR | 3.3 | 5 | 139.94 | 68.82 | 0.9987 | 8.60 | 104 | |
| MC-WR | 2.0 | 5 | 144.79 | 74.78 | 0.9991 | 8.04 | 110 | |
| MC-LA | 3.3 | 4.0 | 10 | 135.37 | 65.77 | 0.9981 | 8.73 | 101 |
| MC-LY | 2.6 | 2.2 | 10 | 139.18 | 84.08 | 0.9986 | 6.23 | 111 |
| MC-LW | 3.2 | 10 | 137.61 | 68.33 | 0.9994 | 8.49 | 102 | |
| MC-LF | 1.2 | 3.4 | 5 | 138.41 | 88.53 | 0.9993 | 5.55 | 113 |
DL = detection limits; MRL = minimum reporting level; PIR = prediction interval of results; %RSD = Relative standard deviation; %Rec = Percent recovery.
Figure 32017 sampling period; (A) July, (B) August, (C) September, and (D) October. Data comparison of total MC (µg/L) detected by LC/MS/MS (bars) and Adda-enzyme-linked immunosorbent assay (Adda-ELISA) (dots).
Summary of the number of times the 12 selected MCs were identified in 122 samples throughout the sampling period.
| Date | D-Asp3 MC-RR | MC-RR | MC-YR | MC-HtyR | MC-LR | D-Asp3-MC-LR | MC-HilR | MC-WR | MC-LA | MC-LY | MC-LW | MC-LF | MS SUM | ELISA MC-LR eq. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07/17 | 5 | 14 | 0 | 0 | 5 | 6 | 2 | 0 | 24 | 0 | 0 | 0 | 56 | 7 |
| 08/17 | 4 | 11 | 6 | 2 | 21 | 5 | 5 | 4 | 21 | 1 | 1 | 1 | 82 | 16 |
| 09/17 | 2 | 8 | 6 | 1 | 22 | 7 | 4 | 2 | 19 | 0 | 1 | 0 | 72 | 17 |
| 10/17 | 0 | 7 | 5 | 1 | 20 | 7 | 2 | 4 | 14 | 1 | 0 | 0 | 61 | 27 |
| Total | 11 | 40 | 17 | 4 | 68 | 25 | 13 | 10 | 78 | 2 | 2 | 1 | 271 | 67 |
Figure 4Percentage of non-US EPA Method 544 MCs detection in samples.
Figure 5Comparison of ELISA and MS/MS for the months of August (●) and October (□).
Precursor, quant, and qual ions for the 12 selected MCs, nodularin, and the surrogate standards.
| Compound | Precursor ( | Quant ions ( | Qual ions ( |
|---|---|---|---|
| D-Asp3-MC-RR | 512.861 | 135.071 | 375.054 |
| MC-RR * | 519.850 | 135.070 | 440.130 |
| Nodularin * | 825.383 | 135.111 | 389.111 |
| MC-LA * | 910.365 | 375.054 | 135.050 |
| D-Asp3-MC-LR | 981.430 | 135.111 | 375.111 |
| MC-LF * | 986.365 | 852.286 | 478.214 |
| MC-LR * | 995.378 | 135.039 | 213.050t |
| MC-LY * | 1002.304 | 494.214 | 868.286 |
| MC-HilR | 1009.461 | 135.111 | 213.054 |
| MC-LW | 1025.639 | 517.214 | 891.286 |
| C2D5 MC-LR * | 1028.743 | 135.097 | 163.083 |
| MC-YR * | 1045.639 | 213.032 | 136.222 |
| MC-HtyR | 1059.426 | 135.111 | 617.222 |
| MC-WR | 1068.452 | 135.097 | 626.183 |
* MCs and nodularin used in US EPA method 544 [11].